JPMORGAN CHASE & CO - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 71 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$24,457,000
+752.2%
649,231
+284.8%
0.00%
Q4 2020$2,870,000
+209.3%
168,735
-16.8%
0.00%
Q3 2020$928,000
-19.3%
202,702
+7.6%
0.00%
Q2 2020$1,150,000
+148.4%
188,408
-7.7%
0.00%
Q1 2020$463,000
-80.9%
204,221
-61.4%
0.00%
Q4 2019$2,429,000
+54.5%
529,188
+30.4%
0.00%
Q3 2019$1,572,000
-19.3%
405,681
+26.0%
0.00%
Q2 2019$1,947,000
-40.3%
321,907
+32.2%
0.00%
-100.0%
Q1 2019$3,263,000
+42.9%
243,503
-0.8%
0.00%0.0%
Q4 2018$2,284,000
-36.3%
245,575
-4.7%
0.00%0.0%
Q3 2018$3,586,000
-5.8%
257,652
+7.0%
0.00%0.0%
Q2 2018$3,807,000
-37.2%
240,789
-31.8%
0.00%0.0%
Q1 2018$6,064,000
-27.6%
353,007
-7.6%
0.00%
-50.0%
Q4 2017$8,374,000
-24.8%
382,023
+33.9%
0.00%0.0%
Q3 2017$11,138,000
+24.0%
285,363
-4.4%
0.00%0.0%
Q2 2017$8,984,000
+119.0%
298,395
+162.9%
0.00%
+100.0%
Q1 2017$4,103,000
-47.4%
113,507
-27.0%
0.00%
-50.0%
Q4 2016$7,793,000
+14.4%
155,500
+19.8%
0.00%0.0%
Q3 2016$6,812,000
+104.3%
129,775
+61.0%
0.00%
+100.0%
Q2 2016$3,334,000
+55466.7%
80,629
+52256.5%
0.00%
Q1 2016$6,0000.0%1540.0%0.00%
Q4 2015$6,000
-97.0%
154
-99.1%
0.00%
Q3 2014$197,00016,7910.00%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q4 2014.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders